Valink Therapeutics

Drug Discovery · London, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics. Valink Therapeutics is based in London, United Kingdom and was founded in 2020. It was valued at $12.6 million at its seed round in Nov 2023, the last priced event on record. It has raised $20.5 million across 1 recorded round; the latest was a $7.6 million seed round in Nov 2023.

PMV mark · valuation
$12.6M
Oct 2026
Priced at
its seed round
Nov 2023
Total raised
$20.5M
Last round
Seed Round
Nov 2023

Who backs Valink Therapeutics?

18 investors
InvestorType
Y CombinatorOther
Creative Destruction LabOther
Metaplanet HoldingsVenture capital
Acequia CapitalOther
University of Oxford—
Oxford Science EnterprisesVenture capital
RedalpineVenture capital
Hoxton VenturesOther
Thomas McInerney—
Saras CapitalHedge fund
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Valink Therapeutics investors

18 investors are on record for Valink Therapeutics, including Y Combinator, Creative Destruction Lab, Metaplanet Holdings and Acequia Capital. The seed round in Nov 2023 drew 8 investors.

Free account
More of Valink Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch Valink Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like Valink Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View